»Cardiovascular Clinical Trials 


Study of FDA Approved Catheter used for the treatment of Ventricular Tachycardia

Francis Marchlinski, MD

No longer recruiting

Why is this study being done?
To provide additional, corroborative safety data for an already FDA approved Catheter for treatment of patients with Ventricular Tachycardia (VT) associated with coronary artery disease.

Who is eligible to participate in this study?
  • over 18 years of age
  • 4 or more documented episodes of spontaneous ventricular tachycardia (VT) or incessant VT associated with coronary artery disease. Episodes are documented by ECG, ICD (implantable defibrillator / pacemaker) interrogation, and/or telemetry strips
  • failed treatment with medication
  • severe heart failure
  • bleeding disorder: thrombocytopenia, clotting disorder
  • MI (heart attack) or cardiac surgery within 2 months
  • VT not associated with coronary artery disease
  • unstable angina
  • certain abnormalities found on echocardiogram

Age range?

What is involved with this study?
Use of an already FDA approved catheter for treatment of VT.

**echocardiogram before and after the procedure (standard practice)

**echocardiogram and follow up visit at 6 months

**Quality of life questionnaire before procedure and at 6 month visit

**annual progress check either at office visit or by phone for 3 years

How long will this study run?
There is no set end point.

Who can I contact for additional information on this trial?
Marty Sweeney, RN, RN, MS
Mary Gnap, RN, RN, CCRC
215- 349-8446
Next Study